Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | PI4KA | P42356 | 1/20 | 0.31 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21923695 | 0.97 | PIK3CA (0.31) | PIK3CAPIM3PIK3CDPIK3CBMTOR | |
| SCHEMBL21213459 | 0.94 | DHFR (0.30) | — | |
| SCHEMBL21212978 | 0.93 | KDM4E (0.33) | PIK3CAPIK3CDPIK3CBMTORPIK3CG | |
| SCHEMBL21924365 | 0.92 | — | — | |
| SCHEMBL21923711 | 0.92 | PIM3 (0.30) | PIM3 | |
| SCHEMBL21213213 | 0.91 | — | — | |
| SCHEMBL21212851 | 0.90 | HPGD (0.32) | — | |
| SCHEMBL21213475 | 0.89 | ALOX5 (0.37) | PIK3CAPIM3PIK3CDPIK3CBMTOR | |
| SCHEMBL21923683 | 0.87 | ALDH1A1 (0.33) | — | |
| SCHEMBL21213546 | 0.86 | PIM3 (0.35) | PIK3CAPIM3PIK3CDPIK3CBMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CYP1B1, CYP2C9, CYP3A4 | PIK3CA 4247/4885PIM3 3287/4885PIK3CD 3926/4885 |
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | CYP1B1, CYP2C9, CYP3A4 | PIK3CA 4247/4885PIM3 3287/4885PIK3CD 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.